Actions of antidiuretic hormone analogues on intact and nystatin-permeabilized frog skins.
The roles of two antidiuretic hormone analogues, namely arginine vasotocin (AVT) and lysine vasopressin (LVP), in solute transport across the ventral abdominal skin of frogs (Rana hexadactyla) were studied using voltage-clamp methods on intact and nystatin-permeabilized preparations. Arginine vasotocin (40 nm), the amphibian analogue of antidiuretic hormone, did not have any effect on the skin of Rana hexadactyla. However, LVP, the porcine antidiuretic hormone, increased the transepithelial potential difference (TEPD) and short-circuit current (SCC) significantly, without affecting the slope conductance. Lysine vasopressin had no action subsequent to addition of amiloride (100 microm) on the apical side or ouabain (10 microm) on the basolateral side. Lysine vasopressin increased slope conductance in the nystatin-permeablized skin while decreasing TEPD. Such a change was not seen in chloride-free solutions. To elucidate the mechanism of action of LVP on intact skin, experiments were done with forskolin and a V(2) receptor blocker. The effects of forskolin (10 microm) were different from those of LVP in that forskolin significantly increased SCC and conductance of the intact skin, while decreasing TEPD. The forskolin-induced increase in conductance was not abolished by amiloride. Use of the V(2) receptor blocker inhibited the effects of LVP. We conclude that AVT does not have an action on the skin of Rana hexadactyla. Lysine vasopressin enhances transepithelial sodium transport by increasing sodium-potassium pump activity, while not affecting the epithelial sodium channel conductance. Lysine vasopressin also enhances an inward-directed conductance on the basolateral membrane, probably a chloride conductance. The action of LVP on the intact frog skin is through the V(2) receptors; however, downstream signalling does not seem to be mediated by cAMP. Analysis of the electrophysiological model of frog skin with LVP allows us additionally to conclude that modulation of channel activity and not carrier-mediated transport affects slope conductance.
Jared
Silviya Rajakumari
SR
Department of Physiology, Christian Medical College, Vellore, Tamilnadu, India.
Rao
J Prakasa
JP
Subramani
Sathya
S
D000584:Amiloride / Q000494:pharmacology; D000818:Animals; D005576:Colforsin / Q000494:pharmacology; D053503:Epithelial Sodium Channels / Q000502:physiology; D008236:Lypressin / Q000494:pharmacology*; D008564:Membrane Potentials / Q000187:drug effects; D009761:Nystatin / Q000494:pharmacology*; D010042:Ouabain / Q000494:pharmacology; D018408:Patch-Clamp Techniques; D010539:Permeability / Q000187:drug effects; D011898:Ranidae; D017483:Receptors, Vasopressin / Q000187:drug effects / Q000502:physiology; D012867:Skin / Q000187:drug effects*; D012879:Skin Physiological Phenomena / Q000187:drug effects*; D000254:Sodium-Potassium-Exchanging ATPase / Q000502:physiology; D014667:Vasopressins / Q000494:pharmacology*; D014668:Vasotocin / Q000494:pharmacology*
D053503:Epithelial Sodium Channels; D017483:Receptors, Vasopressin; D014667:Vasopressins; D009761:Nystatin; D005576:Colforsin; D008236:Lypressin; D010042:Ouabain; D000584:Amiloride; D000254:Sodium-Potassium-Exchanging ATPase; D014668:Vasotocin